Table 1 Patient demographics
From: Aortic valve imaging using 18F-sodium fluoride: impact of triple motion correction
Demographics | Value |
|---|---|
Age (years) | 73 ± 7 |
Gender (Males) | 10 (67.7) |
Body mass index (BMI) | 27.2 ± 4.3 |
Cardiovascular risk factors | |
Diabetes mellitus | 4 (26.7) |
Current smoker | 6 (40.0) |
Hypertension | 11(73.3) |
Hyperlipidemia | 10 (67.7) |
TIA/CVA | 2 (13.3) |
Renal disease | 0 (0) |
CABG | 2 (13.3) |
PCI | 4 (23.7) |
Medications | |
ACE inhibitor | 6 (40.0) |
ARB | 3 (20.0) |
Beta blocker | 7 (56.6) |
Statin | 9 (60.0) |
Aortic stenosis grade | |
Mild | 7 (47.6) |
Moderate | 4 (26.7) |
Severe | 4 (26.7) |
Aortic valve calcium score (Agatston) | 1269 [246–5774] |